Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-06-30

Clinical Trial Update: The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy and safety of combining desloratadine with levocetirizine for chronic idiopathic urticaria and urticaria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)
  • Levocetirizine (Levocetirizine)

Snippet

Sponsor: Lotus Pharmaceutical | Conditions: Chronic Idiopathic Urticaria, Urticaria | Phase 4 | Status: UNKNOWN